Isorhamnetin Inhibits Liver Fibrosis by Reducing Autophagy and Inhibiting Extracellular Matrix Formation via the TGF-β1/Smad3 and TGF-β1/p38 MAPK Pathways

OBJECTIVE: Liver fibrosis is a consequence of wound-healing responses to chronic liver insult and may progress to liver cirrhosis if not controlled. This study investigated the protection against liver fibrosis by isorhamnetin. METHODS: Mouse models of hepatic fibrosis were established by intraperit...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ning, Feng, Jiao, Lu, Xiya, Yao, Zhilu, Liu, Qing, Lv, Yang, Han, Yuru, Deng, Jingfan, Zhou, Yingqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701280/
https://www.ncbi.nlm.nih.gov/pubmed/31467486
http://dx.doi.org/10.1155/2019/6175091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701280/
https://www.ncbi.nlm.nih.gov/pubmed/31467486
http://dx.doi.org/10.1155/2019/6175091

Ejemplares similares